miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
about
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionDevelopment of targeted therapies in treatment of glioblastomaThe Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic DeathMicroRNAs: novel players in cancer diagnosis and therapies.MiR-181b sensitizes glioma cells to teniposide by targeting MDM2.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expressionMiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.miR-181a/b control the assembly of visual circuitry by regulating retinal axon specification and growthTargeting microRNAs: a new action mechanism of natural compounds.MGMT testing--the challenges for biomarker-based glioma treatment.Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.A major role for microRNAs in glioblastoma cancer stem-like cells.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1.Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysismiR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer.miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q26773479-29B6C911-304C-44CE-98F2-5C4DAC701910Q26778787-1B29BE50-33D0-4EC7-8794-EFCA75DC2F13Q28554467-34016E16-D17F-46D4-9AD4-259D0B0DBD10Q33914573-6FB49F0D-53E7-4DEC-893E-0213F6212DA0Q34136136-15A1CF9D-A6AE-4C7E-96FB-81A26F0A79EDQ34409620-FD195C2E-4FBC-41E4-A679-B02560F2B48FQ35315559-140F9A96-958E-483D-8D28-71375B4DF61DQ35788900-45182654-F956-451A-BA83-870A7850294AQ35964266-E5E036AE-2D97-48CE-A178-370BCF8CFC75Q36213516-FE8FF85F-7AFF-47C9-91F2-0159657B0085Q36333514-EB34486B-2DDC-4101-86CF-6C86219B4710Q36846957-67354D5F-E582-4CB6-948E-320F4ACA2C74Q37275605-D0C9D289-872E-4072-96F3-5A27B6132332Q37716654-3582F748-EBCD-4A07-8FE1-632D7FE3095BQ38218848-15F82894-E578-4E87-A26B-8050264C1DEFQ38289553-8E19C0D7-92C6-449B-9AE5-E869585176C0Q38356196-3A6CB216-9D4B-4D74-AAA2-9F5D72E04349Q38546133-C43A9F2A-81A2-4FF3-BEBF-172A7882CB18Q38787480-E37653A5-03BA-4CC1-9ECC-E907A3B04280Q38807203-1FC60A03-4E06-4F61-9664-9FA8F7E0CD5AQ38952149-B06AFAC9-375F-4FCE-9C8A-A2F8A6F26E25Q38973191-2D8601C3-6BF8-4B94-999E-88E3ADD32AB7Q38985855-26C2181D-9535-4D49-B661-921DF1B171E4Q39020586-B2B07D6F-4D36-4093-AF7C-21915BBA2A16Q42207693-AC66C8C6-7993-4B74-B551-E9EBD9E588BCQ47117615-91A00F8E-4E36-4E39-9E7D-285E53B9CC87Q47733035-5D41FBCB-AE82-4575-94D9-46DBF1F7FF4DQ47750291-77F97439-33C9-4D75-A717-5A83E7005291Q48089299-2AE39094-0269-4D8C-879C-6DB393A00ABEQ48185500-4C034B04-3EDA-4DBB-8537-B28EB629ED42Q53059683-4CA856AE-DCBB-4849-B616-E7EE5E715366Q58694197-50AF202A-267B-4AA2-872A-836CDD457907
P2860
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@en
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@nl
type
label
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@en
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@nl
prefLabel
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@en
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@nl
P2093
P2860
P1476
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
@en
P2093
Fu-rong Chen
Zhong-ping Chen
P2860
P2888
P304
P356
10.1007/S00280-013-2180-3
P577
2013-05-05T00:00:00Z